Trent stock price jumps up to 7.4 per cent during Thursday's intraday, as consumer discretionary sectors showed a strong rally across all sectors including auto, FMCG, retail, and consumer durables.

Researchers from the University of California San Diego Sanford Stem Cell Institute have discovered that spaceflight accelerates the aging of human hematopoietic stem and progenitor cells (HSPCs), ...

Gilead Sciences' Kite Pharma has cut off a collaboration with Shoreline Biosciences, ending a research collaboration on off-the-shelf cell therapies that was valued at more than $2.3 billion. The deal ...

LOUISVILLE, Ky. (WAVE) - District leaders are calling it a culture shift within Jefferson County Public Schools. Less than a month into the district’s first school year with a new cellphone ban, JCPS ...

A Western Michigan football player opened the 2025 season Friday night with a new team name on the front of his jersey, and a new display of his own name on the back. Mustafi Al-Garawi, a redshirt ...

Why is the original UGG brand changing its name? In a TikTok posted on Aug. 26, the grandchild of UGG Since 1974’s founders, Todd, announces the name change. “We’re officially dropping those three ...

One of the easiest ways to escape the Groznyj Grad prison cell in Metal Gear Solid Delta: Snake Eater is to make Snake vomit. To do so, open the cure menu as if you were going to extract a bullet or ...

After just four years in business, cell therapy company Appia Bio is shutting down its operations, joining the growing list of startups that have thrown in the towel this year. “I am saddened to share ...

Another cell therapy biotech has run out of steam, this time before ever reaching the clinic. California CAR-T company Appia Bio has closed up shop, founding CEO JeenJoo “JJ” Kang, Ph.D., wrote in an ...

Stimulus check rumors of a $1,390 direct deposit relief payment or a new $1,400 check amount in August for low and middle income taxpayers to be distributed this summer by the IRS, have been debunked ...

Gilead Sciences broke into the field of cancer cell therapies through an acquisition. Now it’s aiming to be part of the next generation of such therapies by buying clinical-stage Interius ...